Quantcast
Job Loss Fears May Boost First-Time Asthma Risk

Job Loss Fears May Boost First-Time Asthma Risk

Emma Dickinson, BMJ-British Medical Journal Finding backs other research indicating link between asthma and work related stress The findings back up other epidemiological studies pointing to a link between the development of asthma and...

Latest Allergology Stories

2014-09-25 23:11:29

AllergyEasy sublingual allergy drops have a strong record for fending off fall allergies. And now they can pack an extra punch thanks to fall serum "boosts" that contain increased concentrations of fall pollen extracts. Mesa, Arizona (PRWEB) September 25, 2014 With its colored leaves and cooler temperatures, fall is a favorite season for many people—but not for the allergic.  Ragweed and other fall pollens can sully the season, turning allergy sufferers into a sniffling,...

2014-09-25 16:26:54

Tuesday, October 7 at 7:00 p.m. ET VIENNA, Va., Sept. 25, 2014 /PRNewswire-USNewswire/ -- Allergy & Asthma Network and the American Latex Allergy Association (ALAA) invite members of the public, health care practitioners and food service workers to participate in two free webinars held in observance of Latex Allergy Awareness Week, the first week of October. Latex allergies impact up to 12 percent of health care workers and 6 percent of the U.S. population, according to the U.S. Centers...

2014-09-23 23:03:13

MarketOptimizer.org adds “OpportunityAnalyzer Allergic Rhinitis – Allergen-Specific Immunotherapy – Opportunity Analysis and Forecast to 2018” to its store. The immunotherapy sales in Japan will reach $47.09m in 2018, with a CAGR of 70.24%. Dallas, Texas (PRWEB) September 23, 2014 The global specific immunotherapy (SIT) market for allergic rhinitis (AR) is highly fragmented, with the US, Europe, and Japan having different SIT formulations available, under different regulatory...

2014-09-17 23:07:45

The $255,000 award will help ITI conduct vaccine validation studies over one year Hershey, PA & Rockville, MD (PRWEB) September 17, 2014 Immunomic Therapeutics, Inc. announced today that it won a Small Business Innovation Research (SBIR) grant to support the continued preclinical development of a multi-nut allergy immunotherapy. The award will provide ITI with approximately $255,000 over one year to conduct vaccine validation studies. Tree nuts, a leading cause of food allergy, affect...

2014-09-08 23:05:17

Concerned consumers, retailers and government inspectors are more conscious of increasing allergen risks in food production as well as effective allergen communication. An upcoming live webinar presented by SGS and METTLER TOLEDO will present the results of a recent SGS industry survey on challenges, needs and gaps in allergen management. (PRWEB) September 08, 2014 Approximately 2 percent of adults and 8 percent of children experience food allergies, and those numbers appears to be...

infant sleeping on fur
2014-09-08 04:00:44

Lauren Anderson, European Lung Foundation Sleeping on animal fur in the first three months of life might reduce the risk of asthma in later childhood a new study has found. The new research, presented at the European Respiratory Society (ERS) International Congress in Munich on September 8, 2014, suggests that exposure to the microbial environment in animal skin and fur could have a protective effect against asthma and allergies. Previous studies have suggested that exposure to a...

2014-09-04 23:10:57

Dr. Anne Marie Salapatek, CSO at Inflamax Research, will be presenting clinical trial data demonstrating the utility of Environmental Exposure Chambers in asthma and allergic rhinitis research at upcoming 2014 European Respiratory Society conference in Munich, Germany, September 6-10. Toronto, ON (PRWEB) September 04, 2014 Inflamax Research Inc., a full-service CRO, announced today that their Chief Science Officer, Dr. Anne Marie Salapatek, will be presenting clinical trial data...

2014-09-03 08:33:19

- Results Expected Q1 2015 - MISSISSAUGA, ON, Sept. 3, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed enrolment in its Phase 2 clinical trial to investigate the safety and efficacy of WF10 in patients with refractory allergic rhinitis. The Company expects the trial to be completed in late 2014 with top-line results anticipated in the first...

2014-08-31 23:00:41

Ragweed is the most common cause of fall hay fever and affects people in virtually every part of the country. AllergyEasy doctors help patients build up immunity to ragweed pollens and stop overreacting to them with hay-fever-like symptoms - and it's as easy as a few drops under the tongue. Mesa, Arizona (PRWEB) August 31, 2014 For many, fall turns daily life into an allergic mess, and ragweed is likely the culprit. Ragweed is the most common cause of fall hay fever and affects 10 to...

2014-08-31 23:00:39

For years, the standard medical advice for nut allergy sufferers has simply been to avoid nuts; however, a treatment known as sublingual immunotherapy ("oral drops") is helping patients reduce their sensitivity to nuts. Mesa, AZ (PRWEB) August 31, 2014 Stuart Agren, M.D., founder of the Family Allergy Clinic in Mesa, Arizona, prescribes sublingual immunotherapy to help his patients struggling with food allergies, which now includes tree nut allergies. Dr. Agren said that it has...


Latest Allergology Reference Libraries

Journal of Allergy and Clinical Immunology
2012-05-14 11:51:18

The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related